Demetrix
Demetrix is a biotechnology company that uses genes found in natural medicines and introduces them to domesticated microbes, for example, the synthetic production of certain chemicals. Demetrix was founded by Dr Haseltine and Jay Keasling.
2
Funding Rounds
$61.0m
Money raised
Overview
Demetrix is a biotechnology company that uses genes found in natural medicines and introduces them to domesticated microbes, for example, the synthetic production of certain chemicals. Demetrix was founded by Dr Haseltine and Jay Keasling.
-
Websites:
- Business model: B2B
- Social accounts:
Funding series
Funding Series Analysis
The company Demetrix has raised a total of $50m in funding over 2 rounds.
Key Insights:
- Demetrix Series A round, July 2019: $50m
- Demetrix Seed round, September 2017: $11m
Demetrix Series A round, July 2019
$50m
Demetrix Seed round, September 2017
$11m
Industries
Demetrix is active in the following industries: